Cellular and molecular mechanisms of resistance to antifolate drugs: new analogues and approaches to overcome the resistance (vol 66, pg 459, 1997)

被引：0

作者：

Takemura, Y ^{[1
]}

Kobayashi, H ^{[1
]}

Miyachi, H ^{[1
]}

机构：

[1] Natl Def Med Coll, Dept Lab Med, Tokorozawa, Saitama 359, Japan

来源：

INTERNATIONAL JOURNAL OF HEMATOLOGY | 1998年 / 67卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：333 / 333

页数：1

共 39 条

[31] Molecular mechanisms involved in resistance of CLL cells towards ABT-737, a specific BCL-2 inhibitor (vol 290, pg 111, 2011)
Sun, Xiao-Ming
Dyer, Martin J.
Cohen, Gerald M.
TOXICOLOGY, 2012, 300 (03) : 168 - 168
[32] Resistance Mechanisms in ROS1-Positive Lung Cancer: New Insight into a Rare but Clinically Important Entity (vol 70, pg 571, 2024)
von Itzstein, Mitchell S.
Gerber, David E.
CLINICAL CHEMISTRY, 2024, 70 (06) : 890 - 890
[33] Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance (vol 6, pg 1067, 2011)
Lawn, Stephen D.
Nicol, Mark P.
FUTURE MICROBIOLOGY, 2012, 7 (08) : 1024 - 1024
[34] Anti-proliferative activity of a new class of taxanes (14β-hydroxy-10-deacetylbaccatin III derivatives) on multidrug-resistance-positive human cancer cells (vol 72, pg 844, 1997)
Distefano, M
Scambia, G
Ferlini, C
Gaggini, C
De Vincenzo, R
Riva, A
Bombardelli, E
Ojima, I
Fattorossi, A
Panici, PB
Mancuso, S
INTERNATIONAL JOURNAL OF CANCER, 1998, 76 (01) : 164 - 164
[35] Molecular mechanisms of acquired resistance to third-generation EGFR-TKIs in EGFR T790M-mutant lung cancer (vol 29, pg i28, 2018)
Ricordel, C.
Friboulet, L.
Facchinetti, F.
Soria, J. -C.
ANNALS OF ONCOLOGY, 2019, 30 (05) : 858 - 858
[36] Characterization of 18 new mutations in COL7A1 in recessive dystrophic epidermolysis bullosa provides evidence for distinct molecular mechanisms underlying defective anchoring fibril formation (vol 61, pg 599, 1997)
Hovnanian
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (06) : 1468 - 1468
[37] HIV-1 protease molecular dynamics of a wild-type and of the V82F/I84V mutant: Possible contributions to drug resistance and a potential new target site for drugs (vol 13, pg 1108, 2004)
Perryman, AL
Lin, JH
McCammon, JA
PROTEIN SCIENCE, 2004, 13 (05) : 1434 - 1434
[38] In-vitro antimicrobial activity of HSR-903, a new fluoroquinolone, against clinical isolates of Klebsiella pneumoniae and Enterobacter cloacae with fluoroquinolone resistance-associated amino acid alterations in GyrA and ParC (vol 40, pg 907, 1997)
Deguchi, T
Yasuda, M
Kawamura, T
Takahashi, Y
Okezaki, E
Nagata, O
Kato, H
Kawada, Y
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (06) : 672 - 673
[39] THE EBNA2-RELATED RESISTANCE TOWARDS ALPHA-INTERFERON (IFN-ALPHA) IN BURKITTS-LYMPHOMA CELLS EFFECTS INDUCTION OF IFN-INDUCED GENES BUT NOT THE ACTIVATION OF TRANSCRIPTION FACTOR ISGF-3 (MOLECULAR AND CELLULAR BIOLOGY, VOL 12, PG 4932, 1992)
KANDA, K
DECKER, T
AMAN, P
WAHLSTROM, M
VONGABAIN, A
KALLIN, B
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (03) : 1981 - 1981

← 1 2 3 4 →